News & Events



BD Celebrates Opening of New Manufacturing Facility in San Luis Potosi, Mexico


Contact: Colleen T. White
Corporate Communications
(201) 847-5369
Email: colleen_white@bd.com

San Luis Potosi, Mexico (March 01, 2010) -- BD (Becton, Dickinson and Company), a leading global medical technology company, today celebrated the grand opening of its newest production facility in Mexico. The new U.S. $16.6 million facility will be approximately 80,000-square-feet upon completion, which is expected in early 2011, and is expected to employ approximately 140 individuals at full capacity. 
 
“Our new facility in San Luis Potosi will help enable BD to meet increasing global demand for its products,” said William A. Kozy, BD Executive Vice President. “We are grateful for the support we have received from the Mexican authorities, especially the San Luis Potosi government, for this investment. BD has a long history in Mexico, and today we are pleased to be celebrating the next chapter.”

The products manufactured at the new plant are cut stainless steel tubes which will be sent to other BD plants for finishing operations, including grinding, cleaning and needle assembly. The plant and its products manufactured there will comply with BD’s high standards for quality, safety, reliability and business continuity.  Additionally, the building design incorporates features intended to reduce energy and water consumption, reflecting BD's commitment to environmental stewardship.

The San Luis Potosi facility is part of the U.S. $200 million investment currently underway that was previously announced in Los Pinos with the Honorable Felipe Calderon Hinojosa, President of Mexico, in April 2009. BD first established operations in Mexico in 1957. Today, the Company has facilities in San Luis Potosi; Cuautitlán Izcalli, in the State of México; Nogales, Sonora; and Mexico City. BD employs more than 3,100 associates in Mexico.
 
About BD
BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world.  BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.  For more information, please visit www.bd.com.

 

Unless otherwise noted, BD, BD logo and all other trademarks are property of Becton Dickinson and Company. © 2013 BD